期刊文献+

首次确诊HIV感染者的处理原则(下)

Management of Newly Diagnosed HIV Infection
下载PDF
导出
摘要 当越来越多的人感染HIV,如何筛选HIV感染者并正确处理首次确诊的HIV感染者都是值得探讨的问题。美国主要的专业机构发布的指南认为-广泛开展筛检,对首次确诊HIV感染者进行恰当的评估后给予合理的抗病毒治疗及必要的机会性感染的预防;在长期的诊治过程中,为病人提供持续的关怀,督促服药,监测药物毒副反应及HIV-1RNA载量和CD4^+细胞计数都是至关重要的。 As more and more persons have infected HIV, it is vital for us to deal with many problems such as how to screen for HIV infection, how to dispose newly diagnosed HIV infection, since HIV infection can be cured like other chronic disease. So correct management of newly diagnosed HIV infection must be taken up such as widely screening for HIV infection, evaluation of the patients, appropriate initiation of antiretroviral therapy, prophylaxis against opportunistic infections, giving continuous care and counseling to patients, providing ongoing support of drug adherence, monitoring plasma HIV-1 RNA levels and CD4^+ cell counts and so on.
出处 《世界感染杂志》 2006年第3期261-263,275,共4页 World Journal of Infection
关键词 首次确诊 HIV 处理 Newly diagnosed HIV infection Management
  • 相关文献

参考文献10

  • 1Bozzette SA, Finkelstein DM, Spector SA, et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection [J]. N Engl J Med, 1995, 332:693-699.
  • 2Opravil M, Ledergerber B, Furrer H, et al. Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count>350×10^6/1[J]. AIDS, 2002, 16: 1371-1381.
  • 3Sterling TR, Chaisson RE, Moore RD. Initiation of highly active antiretroviral therapy at CD4^+ T lymphocyte counts of >350 cells/mm^3: disease progression, treatment durability, and drug toxicity [J]. Clin Infect Dis, 2003, 36: 812-815.
  • 4Ahdieh-Grant L, Yamashitta TE, Phair JE et al. When to initiate highly active antiretroviral therapy: a cohort approach [J]. Am J Epidemiol, 2003, 157: 738-746.
  • 5Chun TW, Justement JS, Lempicki RA, et al. Gene expression and viral production in latently infected, resting CD4^+ T cells in viremic versus aviremic HIV-infected individuals [J]. Proc Natl Acad Sci USA, 2003, 100: 1908-1913.
  • 6Bartlett JA, Fath MJ, DeMasi R, et al. An updated meta-analysis of triple combination therapy in antiretroviral-naive HIV-infected adults.Presented at the 12th Conference on Retroviruses and Opportunistic Infections, Boston, February 22-25, 2005. abstract.
  • 7Pozniak AL, Gallant JE, DeJesus E, et al. Superior outcome for tenofovir DF, emtricitabine and efavirenz compared to fixed dose zidovudine/lamivudine and efavirenz in antiretroviral naive patients.Presented at the 3^rd IAS Conference on Pathogenesis and Treatment,Rio de Jameiro, July 24-27, 2005. abstract.
  • 8Gulick RM, Ribaudo HJ, Shikuma CM, et al. Triple-nucleoside regimnts versus efavirenz-containing regiments for the initial treatment of HIV- 1 infection [J]. N Engl J Med, 2004. 350:1850-1861.
  • 9Nettles RE, Kieffer TL, Kwon E et al. Intermittent HIV-1 viremia(Blips) and drug resistance in patients receiving HAART [J]. JAMA,2005, 293: 817-829.
  • 10Benhamou Y. Antiretroviral therapy and HIVhaepatitis B virus coinfection [J]. Clin Infect Dis, 2004, 38: Suppl 2: S98-S103.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部